IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections

Mucosal Immunology

Volumn 7, Issue 5, 2014, Pages 1036-1044

  Wang, Y Y ^a   Kannan, A ^b   Nunn, K L ^b   Murphy, M A ^c   Subramani, D B ^c   Moench, T ^d   Cone, R ^a   Lai, S K ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA and North Carolina State University   (United States)

^c University of North Carolina   (United States)

^d REPROTECT INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL IMMUNOGLOBULIN G; MUCIN; NEUTRALIZING ANTIBODY; PARAPROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; GLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CERVICOVAGINAL MUCUS; CONTROLLED STUDY; CORRELATIONAL STUDY; DEGLYCOSYLATION; EX VIVO STUDY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; IMMUNOGLOBULIN PRODUCTION; INFECTION PREVENTION; MOLECULAR INTERACTION; MOUSE; MUCUS; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; VAGINA MUCOSA; VAGINAL LAVAGE; VAGINITIS; VIRION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS NEUTRALIZATION; ADULT; ANIMAL; CHLOROCEBUS AETHIOPS; DISEASE MODEL; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; IMMUNOLOGY; METABOLISM; SIMPLEXVIRUS; UTERINE CERVIX MUCUS; VAGINA; VERO CELL LINE; VIROLOGY; YOUNG ADULT; ANIMAL TISSUE; ANTIBODY RESPONSE; BIOACCUMULATION; DRUG POTENCY; HERPES SIMPLEX VIRUS; INNATE IMMUNITY; PROTEIN PURIFICATION; VACCINATION; VIRUS ATTACHMENT;

ADULT; ANIMALS; CERCOPITHECUS AETHIOPS; CERVIX MUCUS; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOGLOBULIN G; MICE; SIMPLEXVIRUS; VAGINA; VERO CELLS; YOUNG ADULT;

EID: 84899806985     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.120     Document Type: Article

References (56)

1. Li, Z.,Palaniyandi, S., Zeng, R., Tuo,W.,Roopenian, D.C.&Zhu, X. Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc. Natl. Acad. Sci. USA 108, 4388-4393 (2011).
2. Usala, S.J., Usala, F.O., Haciski, R., Holt, J.A. & Schumacher, G.F. IgG and IgA content of vaginal fluid during the menstrual cycle. J. Reprod. Med. 34, 292-294 (1989).
3. Cone, R.A. Mucus. In Handbook of Mucosal Immunology, 3rd edn. Ogra, P.L. & Mestecky, J. & Lamm, M.E. & Strober,W. & Bienenstock, J. & McGhee, J.R., eds) 43-64 (Academic Press, San Diego, CA, USA, 1999).
4. Hill, J.A. & Anderson, D.J. Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. Am. J. Obstet. Gynecol. 166, 720-726 (1992).
5. Schumacher, G.F. Immunology of spermatozoa and cervical mucus. Hum. Reprod. 3, 289-300 (1988).
6. Kresge, K.J. The Mysteries of Protection. IAVI Report, Vol. 13, Number 5 [Internet] (2009).
7. Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209-2220 (2009).
8. Brockman, M.A. & Knipe, D.M. Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection. Vaccine 26 (Suppl 8), I94-I99 (2008).
9. Hook, L.M., Lubinski, J.M., Jiang, M., Pangburn, M.K. & Friedman, H.M. Herpes simplex virus type 1 and 2 glycoprotein C prevents complementmediated neutralization induced by natural immunoglobulin M antibody. J. Virol. 80, 4038-4046 (2006).
10. Lubinski, J., Wang, L., Mastellos, D., Sahu, A., Lambris, J.D. & Friedman, H.M. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J. Exp. Med. 190, 1637-1646 (1999).
11. Lai, S.K. et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J. Virol. 83, 11196-11200 (2009).
12. Olmsted, S.S., Padgett, J.L., Yudin, A.I., Whaley, K.J., Moench, T.R. & Cone, R.A. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys. J. 81, 1930-1937 (2001).
13. Cole, A.M. Innate host defense of human vaginal and cervical mucosae. Curr. Top. Microbiol. Immunol. 306, 199-230 (2006).
14. Doss, M., White, M.R., Tecle, T. & Hartshorn, K.L. Human defensins and LL-37 in mucosal immunity. J. Leukoc. Biol. 87, 79-92 (2010).
15. Lai, S.K. et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Natl. Acad. Sci. USA 104, 1482-1487 (2007).
16. Lai, S.K., Wang, Y.Y., Hida, K., Cone, R. & Hanes, J. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc. Natl. Acad. Sci. USA 107, 598-603 (2010).
17. Hamburger, A.E., Bjorkman, P.J. & Herr, A.B. Structural insights into antibody-mediated mucosal immunity. Curr. Top.Microbiol. Immunol. 308, 173-204 (2006).
18. Mantis, N.J., Rol, N. & Corthesy, B. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 4, 603-611 (2011).
19. Berzofsky, J.A., Berkower, I.J. & Epstein, S.L. Antigen-antibody interactions and monoclonal antibodies. In Fundamental Immunology (Paul,W.E., ed) 421-465 (The Raven Press, New York, NY, USA, 1993).
20. Saltzman, W.M., Radomsky, M.L., Whaley, K.J. & Cone, R.A. Antibody diffusion in human cervical mucus. Biophys. J. 66, 508-515 (1994).
21. Ha, S. et al. Isolation and characterization of IgG1 with asymmetrical Fc glycosylation. Glycobiology 21, 1087-1096 (2011).
22. Meysick, K.C. & Garber, G.E. Interactions between Trichomonas vaginalis and vaginal flora in a mouse model. J. Parasitol. 78, 157-160 (1992).
23. Ey, P.L., Russell-Jones, G.J. & Jenkin, C.R. Isotypes of mouse IgG-I. Evidence for 'non-complement-fixing' IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement. Mol. Immunol. 17, 699-710 (1980).
24. Michaelsen, T.E., Kolberg, J., Aase, A.,Herstad, T.K. & Hoiby, E.A. The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis. Scand. J. Immunol. 59, 34-39 (2004).
25. Neuberger, M.S. & Rajewsky, K. Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immunol. 11, 1012-1016 (1981).
26. Akiyama, Y., Lubeck, M.D., Steplewski, Z. & Koprowski, H. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon. Cancer Res. 44, 5127-5131 (1984).
27. Kipps, T.J., Parham, P., Punt, J. & Herzenberg, L.A. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J. Exp. Med. 161, 1-17 (1985).
28. Zeitlin, L., Whaley, K.J., Hegarty, T.A., Moench, T.R. & Cone, R.A. Tests of vaginal microbicides in the mouse genital herpes model. Contraception 56, 329-335 (1997).
29. Stefanidou, M. et al. Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy. J. Virol. 87, 1443-1453 (2013).
30. Yuan,W.,Dasgupta, A. & Cresswell, P. Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat. Immunol. 7, 835-842 (2006).
31. Jager, S., Kremer, J., Kuiken, J. & Mulder, I. The significance of the Fc part of antispermatozoal antibodies for the shaking phenomenon in the spermcervical mucus contact test. Fertil. Steril. 36, 792-797 (1981).
32. Kremer, J. & Jager, S. The sperm-cervical mucus contact test: a preliminary report. Fertil. Steril. 27, 335-340 (1976).
33. Phalipon, A., Cardona, A., Kraehenbuhl, J.P., Edelman, L., Sansonetti, P.J. & Corthesy, B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 17, 107-115 (2002).
34. Fahrbach, K.M.,Malykhina, O., Stieh, D.J. & Hope, T.J. Differential binding of IgG and IgA to mucus of the female reproductive tract. PLoS One 8, e76176 (2013).
35. Kobayashi, K. et al. Distribution and partial characterisation of IgG Fc binding protein in various mucin producing cells and body fluids. Gut 51, 169-176 (2002).
36. Johansson, M.E., Larsson, J.M. & Hansson, G.C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. USA 108 (Suppl 1), 4659-4665 (2011).
37. Johansson,M.E., Thomsson, K.A. & Hansson, G.C. Proteomic analyses of the twomucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein. J. Proteome Res. 8, 3549-3557 (2009).
38. Clamp, J.R. The relationship between secretory immunoglobulin A and mucus [proceedings]. Biochem. Soc. Trans. 5, 1579-1581 (1977).
39. Crowther, R., Lichtman, S., Forstner, J. & Forstner, G. Failure to show secretory IgA binding by rat intestinal mucin. Fed. Proc. 44, 691 (1985).
40. Kobayashi, K., Blaser,M.J. & Brown,W.R. Identification of a unique IgG Fc binding site in human intestinal epithelium. J. Immunol. 143, 2567-2574 (1989).
41. Andersch-Bjorkman, Y., Thomsson, K.A., Holmen Larsson, J.M., Ekerhovd, E. & Hansson, G.C. Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle. Mol. Cell. Proteomics 6, 708-716 (2007).
42. Dasari, S. et al. Comprehensive proteomic analysis of human cervicalvaginal fluid. J. Proteome Res. 6, 1258-1268 (2007).
43. Shaw, J.L., Smith, C.R. & Diamandis, E.P. Proteomic analysis of human cervico-vaginal fluid. J. Proteome Res. 6, 2859-2865 (2007).
44. Tang, L.J. et al. Proteomic analysis of human cervical-vaginal fluids. J. Proteome Res. 6, 2874-2883 (2007).
45. Amsel, R., Totten, P.A., Spiegel, C.A., Chen, K.C., Eschenbach, D. & Holmes, K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14-22 (1983).
46. Shukair, S.A. et al. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol. 6, 427-434 (2013).
47. Belshe, R.B. et al. Efficacy results of a trial of a herpes simplex vaccine. N. Engl. J. Med. 366, 34-43 (2012).
48. Leroux-Roels, G., Clement, F., Vandepapeliere, P., Fourneau, M., Heineman, T.C. & Dubin, G. Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults: a double-blind randomized trial. Hum. Vaccin Immunother. 9, 1254-1262 (2013).
49. Lai, S.K.,Wang, Y.Y. & Hanes, J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 61, 158-171 (2009).
50. Kocevar-Nared, J., Kristl, J. & Smid-Korbar, J. Comparative rheological investigation of crude gastric mucin and natural gastric mucus. Biomaterials 18, 677-681 (1997).
51. Elliott, G. & O'Hare, P. Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J. Virol. 73, 4110-4119 (1999).
52. Heine, J.W., Honess, R.W., Cassai, E. & Roizman, B. Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J. Virol. 14, 640-651 (1974).
53. Nugent, R.P., Krohn, M.A. & Hillier, S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29, 297-301 (1991).
54. Apgar, J., Tseng, Y., Fedorov, E., Herwig, M.B., Almo, S.C. & Wirtz, D. Multiple-particle tracking measurements of heterogeneities in solutions of actin filaments and actin bundles. Biophys. J. 79, 1095-1106 (2000).
55. Cone, R.A., Hoen, T.,Wong, X., Abusuwwa, R., Anderson, D.J. & Moench, T.R. Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect. Dis. 6, 90 (2006).
56. Crowther, R.S. & Wetmore, R.F. Fluorometric assay of O-linked glycoproteins by reaction with 2-cyanoacetamide. Anal. Biochem. 163, 170-174 (1987).